Clinical Trials Logo

Clinical Trial Summary

Patients presented with acute pain from renal colic, the standard of care are prescribed NSAIDs, most common drug used is intramuscular (IM) Diclofenac injected at the gluteal muscle. Due to adverse effects in some patients, the nursing council has banned the injection by nurses. Since then, there has been a change in treatment by using intravascular (IV) Tramadol. According to various research, Diclofenac has a higher efficacy in controlling pain compared to other medications. In clinical practice, Tramadol has less efficacy of decreasing pain and a longer onset of action. At presence, there has been no research performed comparing the efficacy between these two drugs especially from the viewpoint of time dimension.


Clinical Trial Description

To compare the efficacy Diclofenac 75 mg IM versus Tramadol 50 mg IV in patients with acute pain from renal colic. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06231043
Study type Interventional
Source Lampang Hospital
Contact
Status Completed
Phase Phase 4
Start date April 27, 2022
Completion date April 15, 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT01685658 - Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations Phase 4
Completed NCT02878148 - Conditional Imaging Prescription Strategy for Exploration of Acute Uncomplicated Renal Colic N/A
Completed NCT03704623 - Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic Phase 4
Completed NCT01339624 - Nasal Fentanyl And Renal Colic N/A
Completed NCT04441762 - Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management. Phase 2/Phase 3